Jade Biosciences approves 2026 Inducement Plan, reserving 1.75M shares for new hires

Jade Biosciences, Inc.

Board approved 2026 Employment Inducement Stock Incentive Plan, effective March 31, 2026.
1,750,000 shares of common stock reserved for issuance under the plan.
Awards limited to new employees as inducement material to hire, per Nasdaq Rule 5635(c)(4).
Plan substantially similar to 2025 Stock Incentive Plan but no incentive stock options allowed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.